In this panel sponsored by Precision ADVANCE, Clare Sarvary Fourrier, SVP of Operational Strategy (EU) for Precision for Medicine moderates a discussion with industry experts to share perspectives on the current state of the cell and gene therapy industry and provide key insights in shortening time-to-market for advanced therapies.
- Alex Grosvenor SVP, PRECISIONadvisors | Precision Value & Health
- Dave Lennon President | Novartis Gene Therapies
- Anshul Mangal President | Project Farma (PF) & Precision ADVANCE
- Parag V. Meswani Chief Commercial Officer | Sio Gene Therapies
- Pascal Touchon President & CEO | Atara Biotherapeutics